Majority of patients with colorectal cancer do not experience social difficulties
the ONA take:
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer (CRC) do experience poor social outcomes.
Researchers based at the Leeds Institute of Cancer and Pathology, University of Leeds, St. James's University Hospital, United Kingdom, sent questionnaires to all 12- to 36-month CRC survivors diagnosed in 2010 or 2011 and treated by the English National Health Service. The questionnaire assessed clinical data, sociodemographic information, and included the Social Difficulties Inventory.
The latter inventory is a 16-item scale of social distress that reviews everyday living conditions, self and others subscales, and related items.
Approximately 82% of the 21,802 respondents completed all social distress items. (Overall response rate of the 34,467 individuals contacted was 63.3%.)
Approximately 15% OF individuals reported experiencing social distress. Multivariable analysis indicated that having three or more long-term conditions was a strong precursor to social distress.
It was determined that the majority of individuals diagnosed with CRC experience no social distress, and that the risk factors (clinical and otherwise) can be used to target support for those who are more likely to experience social difficulties.
Although the majority observe no difficulties, a portion of individuals diagnosed with colorectal cancer do experience poor social outcomes.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|